Improves access to lower-cost generic and biosimilar drugs.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 1 Sponsors

May 14, 2026 · Senate

Introduced in the Senate, Referred to Senate Commerce Committee

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 4%, measured from NJ's completed sessions
Momentum -5 26/100 from the pace of recorded action
Time since last action -22 151 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.